RxDoctor Payments Data

Douglas Reh, MD

Otolaryngology · Lutherville Timonium, MDNPI 1982725917

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (44.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Optinose US, Inc. at 39.7% of the total. 2025 is the largest year on record at $48,598, 2.0 times the $24,237 reported in 2019. Among otolaryngology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$230,751in general payments, 2019–2025

Across 408 payments — averaging $565.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$92K
  • Neurent Medical Limited$37K
  • Sanofi$27K
  • Integra Lifesciences Corporation$27K
  • Medical Device Business Services, Inc.$23K
  • Acclarent, Inc$18K
  • plus $7K from 13 others
$450,333in research payments, 2019–2025

Across 71 payments — averaging $6342.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Neurent Medical Limited$425K
  • Optinose US, Inc.$14K
  • Aerin Medical Inc.$5K
  • GSK$4K
  • Paratek Pharmaceuticals, Inc.$2K

What the payments were for

  • Consulting fees$103,60645%
  • Speaking & faculty fees$91,58140%
  • Travel & lodging$21,2059%
  • Food & beverage$14,2366%
  • Education$1220%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$230,751 in reported general payments places this provider in the 95th percentile of 222 otolaryngology providers in Maryland.

See all otolaryngology providers in Maryland

Medicare billing

Part B allowed, 2024
$347,268
Medicare patients
671
Services billed
2,347

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide258$8,171
Mometasone Furoate16$2,597
Budesonide11$2,569
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth14$1,812
Azelastine Hcl48$1,520
Montelukast Sodium49$981
Azithromycin69$953
Methylprednisolone101$638
Fluocinolone Acetonide Oil18$591
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav55$537
Mupirocin80$503
Doxycycline Hyclate31$313
Prednisone26$81
Oxycodone Hcl14$45
Alprazolam15$8

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Lutherville Timonium

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →